Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;23(12):2281-2288.
doi: 10.1038/s41436-021-01271-1. Epub 2021 Jul 29.

Exploring the motivations of research participants who chose not to learn medically actionable secondary genetic findings about themselves

Affiliations

Exploring the motivations of research participants who chose not to learn medically actionable secondary genetic findings about themselves

Will Schupmann et al. Genet Med. 2021 Dec.

Abstract

Purpose: Proposals to return medically actionable secondary genetic findings (SFs) in the clinical and research settings have generated controversy regarding whether to solicit individuals' preferences about their "right not to know" genetic information. This study contributes to the debate by surveying research participants who have actively decided whether to accept or refuse SFs.

Methods: Participants were drawn from a large National Institutes of Health (NIH) environmental health study. Participants who had accepted SFs (n = 148) or refused SFs (n = 83) were given more detailed information about the types of SFs researchers could return and were given an opportunity to revise their original decision.

Results: Forty-one of 83 initial refusers (49.4%) opted to receive SFs following the informational intervention. Nearly 75% of these "reversible refusers" thought they had originally accepted SFs. The 50.6% of initial refusers who continued to refuse ("persistent refusers") demonstrated high levels of understanding of which SFs would be returned postintervention. The most prominent reason for refusing was concern about becoming worried or sad (43.8%).

Conclusion: This study demonstrates the need for a more robust informed consent process when soliciting research participants' preferences about receiving SFs. We also suggest that our data support implementing a default practice of returning SFs without actively soliciting preferences.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest statement: The authors have no conflicts of interest to declare.

Figures

Figure 1.
Figure 1.. Beliefs about the Kinds of Genetic SFs that Could be Returned
Notes: Pearson’s Chi-squared tests were conducted for A and C. McNemar’s tests were conducted for B. C does not include the 6 respondents who switched from accepting to refusing. “Persistent Refusers” in C are the 42 participants who refused at both timepoints

Comment in

References

    1. Presidential Commission for the Study of Bioethical Issues. Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts. 2013. - PubMed
    1. Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565–574. - PMC - PubMed
    1. Miller DT, Lee K, Chung WK, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021. - PubMed
    1. Berkman BE. Refuting the Right Not to Know. J Health Care Law Policy. 2017;19(1):1–75. - PMC - PubMed
    1. Burke W, Matheny Antommaria AH, Bennett R, et al. Recommendations for returning genomic incidental findings? We need to talk! Genet Med. 2013;15(11):854–859. - PMC - PubMed

Publication types

LinkOut - more resources